ML19270G979
| ML19270G979 | |
| Person / Time | |
|---|---|
| Site: | -NewDkt |
| Issue date: | 09/26/2019 |
| From: | Monica Ford NRC Region 1 |
| To: | Tomayko Group |
| References | |
| 615382 | |
| Download: ML19270G979 (3) | |
Text
NRC FORM 374 PAGE 1 OF 3 PAGES U.S. NUCLEAR REGULATORY COMMISSION MATERIALS LICENSE Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, Code of Federal Regulations, Chapter I, Parts 30, 31, 32, 33, 34, 35, 36, 37, 39, 40, 70 and 71, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct, source, and special nuclear material designated below; to use such material for the purpose(s) and at the place(s} designated below; to deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is subject to all applicable rules, regulations, and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below.
Licensee In accordance with email dated 4. Expiration Date: June 30, 2026 July 02, 2019.
- 1. The Tomayko Group, L.L.C
- 5. Docket No.: 030-39197 t--------------f
- 2. 2403 Sidney Street, Suite 220B 3. License number: 37-28520-03 Reference No.:
Pittsburgh, PA 15203
- 6. Byproduct, source, 7. Chemical and/or physical form 8. Maximum amount that licensee 9. Authorized use and/or special nuclear may possess at any one time material under this license A. Any byproduct material A. Any A. As Needed A. For use in uptake, dilution and permitted by 10 CFR excretion studies permitted by 10 CFR 35.100 35.100.
B. Any byproduct material B. Any B. As Needed B. For use in imaging and localization permitted by 10 CFR studies permitted by 10 CFR 35.200.
35.200 CONDITIONS
- 10. Licensed material may be used or stored incident to mobile nuclear medicine activities at the licensee's facilities located at 50 Timber Lane, South Burlington, Vermont and at temporary job sites of the licensee anywhere the State of Vermont maintains jurisdiction for regulating the use of licensed material.
- 11. The Radiation Safety Officer for this license is Mark Perna, M.S. DABR
NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 2 OF 3 PAGES License Number Docket or Reference Number 37-28520-03 030-39197 MATERIALS LICENSE SUPPLEMENTARY SHEET
- 12. Licensed material shall only be used by, or under the supervision of:
A. Individuals permitted to work as authorized users in accordance with 10 CFR 35.13 and 10 CFR 35.14.
B. The following individuals are authorized users for the material and medical uses as indicated:
Authorized User(M.D.,D.O.,etc.) Material and Use Richard R. Black, D.O. 10 CFR 35.200 G. David Burtner, M.D 10 CFR 35.100, 10 CFR 35.200 Steffen Hillemann, M.D. 10 CFR 35.200 Janet Kirwan, M.D. 10 CFR 35.200 David C. Rosiello, M.D. 10 CFR 35.100, 10 CFR'35.200 Mark Younis, M.D. 10 CFR 35.100, 10 CFR 35.200
- 13. In addition to the possession limits in Item 8, the licensee shall further restrict the possession of licensed material to quantities below the minimum limit specified in 10 CFR 30.35(d) for establishing decommissioning financial assurance.
NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 3 OF 3 PAGES License Number Docket or Reference Number 37-28520-03 030-39197 MATERIALS LICENSE SUPPLEMENTARY SHEET
- 14. Except as specifically provided otherwise in this license, the licensee shall conduct its program in accordance with the statements, representations, and procedures contained in the documents, including any enclosures, listed below. This license condition applies only to those procedures that are required to be submitted in accordance with the regulations. Additionally, this license condition does not limit the licensee's ability to make changes to the radiation protection program as provided for in 10 CFR 35.26. The U.S. Nuclear Regulatory Commission's regulations shall govern unless the statements, representations, and procedures in the licensee's application and correspondence are more restrictive than the regulations.
A. Application dated November 17, 2015 [ML16011A131]
B. Letter dated March 10, 2016 [ML16111B175]
C. Letter dated October 31, 2017 [ML17326A224].
D. Letter dated October 9, 2018 [ML18292A678]
E. Letter dated June 14, 2019 [ML19178A309]
FOR THE U.S. NUCLEAR REGULATORY COMMISSION Date: September 26, 2019 By:_}L~i,;
vMonica Ford c:37' Region 1